T S Litvinova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Tramal, the drug produced by the "Grunenthal" firm (FRG) was used in the treatment of 478 patients with malignant neoplasms. In 24.46% patients, the side effects were noted, which were characteristic of the majority of analgetics and didn't threaten the life. The authors recommend to use Tramal for cupping off the pain syndrome at the postoperative period,(More)
  • 1